Randomized Clinical Trial of Restory, an Online Prolonged Exposure Therapy for Adults with PTSD from Sexual Abuse

What this Trial Is About

Researchers are evaluating Restory, a new anonymous internet-delivered cognitive behavioral therapy iCBT program using prolonged exposure therapy designed specifically for adults who are victims of sexual abuse and suffer from post-traumatic stress disorder PTSD. The study is a randomized controlled trial comparing Restory to a waitlist control group to determine if Restory reduces PTSD symptom severity as measured by the PCL-5 score. This addresses the lack of accessible, specialized treatment options for sexual abuse survivors, especially those facing stigma, shame, or barriers to traditional care. Restory consists of eight weekly modules delivered online, each including psychoeducational content tailored to sexual abuse survivors, explanations of therapy methods, and homework assignments. After completing each module, participants receive personalized feedback from a therapist before moving to the next. The waitlist control group delays starting Restory for at least nine weeks while responding to the same questionnaires. The program aims to provide flexible, anonymous trauma-focused care that can be accessed nationwide without in-person visits. Participants will self-refer and register through the study platform and are asked to complete questionnaires before, during, and after treatment, including follow-ups at 1 and 6 months post-treatment. Outcomes measured include PTSD symptom severity, complex PTSD symptoms, and depressive symptoms. The study includes monitoring of safety, medication stability, and symptom changes. The total participation spans from initial screening through the treatment and follow-up periods, supporting ongoing assessment of Restorys impact.

Evaluation of Restory - an Online Trauma Treatment for Victims of Sexual Abuse